Chemotherapy-induced Neutropenia Clinical Trials

53 clinical trials for Chemotherapy-induced Neutropenia across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid Tumors — RECRUITING · PHASE2
• Home Monitoring of Complete Blood Count Performed by Patients - a Pilot Study on the Implementation Process in South Baltic Countries. — RECRUITING
• Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor — RECRUITING
• Breath Analysis for the Detection of Invasive Fungal Infections — RECRUITING
• Clinical Study on the Safety, Efficacy and Pharmacokinetics of Telpegfilgrastim in Pediatric Cancer Patients with Chemotherapy — RECRUITING · PHASE2
• Danish Elder Lymphoma Patient Hematopoietic Investigation — RECRUITING
• A clinical study to assess the safety and effectiveness of tbo-filgrastim in infants,children and adolescents with solid tumors without bone marrow involvement — COMPLETED · PHASE2
• Comparable efficacy and safety profiles of daily injection of BK0023 and filgrastim (Neupogen®) in chemotherapy-induced neutropenia: a multinational, multicenter, investigator blind, randomised, parallel group study in women with breast cancer — ACTIVE_NOT_RECRUITING · PHASE3
• G-CSF-Induced Bone Pain and Supportive Care Approaches — COMPLETED
• Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab — TERMINATED · PHASE2
• A Multi-cohort Study of Efbemalenograstim Alfa Injection for Preventing ANC Reduction in Solid Tumor Patients Post Immune-chemotherapy. — NOT_YET_RECRUITING · NA
• Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 3 — COMPLETED · PHASE3
• Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2 — COMPLETED · PHASE2
• Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel — COMPLETED · PHASE2
• Study to Evaluate the Usability of PointCheck — COMPLETED
• Neugranin in Breast Cancer Participants Receiving Doxorubicin/Docetaxel — COMPLETED · PHASE3
• Trabectedin/Caelyx vs Cisplatin Hypersensitivity in Relapsed Ovarian Cancer Patients Allergic to Platinum — COMPLETED
• Feasibility and Comparison of Continuously Monitored Vital Signs in Pediatric Patients With Cancer. — COMPLETED
• Mecapegfilgrastim(PEG-G-CSF) for Prophylaxis of Chemotherapy-induced Neutropenia in Patients With Lymphoma — OTHER · PHASE2
• Feasibility of Monitoring Health Data in Pediatric Patients Undergoing Chemotherapy — COMPLETED
• Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia — OTHER · PHASE3
• Safety and Effectiveness Assessment of PeGagen® (Pegfilgrastim) in the Prevention of Chemotherapy-induced FN — COMPLETED
• Starting Granulocyte Colony-Stimulating Factor at 1 Day vs 3 Days Following Chemotherapy in Pediatric Cancer Patients — OTHER · PHASE4
• Plinabulin iv Solution in Prevention of TAC Induced Neutropenia — COMPLETED · PHASE2
• Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer — OTHER · PHASE3
• Effect of GM1 in Prevention of Oxaliplatin Induced Neurotoxicity in Stage II/III Colorectal Cancer — COMPLETED · PHASE3
• Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients — COMPLETED · PHASE2
• Use of Biosimilar Nivestim® to Prevent Chemo-induced Neutropenia. Real Life Study — TERMINATED
• Real World Study of PEG-rhG-CSF in Prevention of Chemotherapy-induced Neutropenia — OTHER
• Randomized Phase 2, Dose-finding Efficacy, Safety Study of ANF-RHO™ Versus Neulasta® in Chemotherapy-Induced Neutropenia — TERMINATED · PHASE2
• G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients — OTHER · PHASE4
• Efficacy, Safety and Cost-effectiveness of PEG-rhG-CSF for Primary vs Secondary Prophylaxis — OTHER
• Pegteograstim in Children With Solid Tumors — OTHER · PHASE2
• Community-Led Action Research in Oncology: Improving Symptom Management — COMPLETED · NA
• Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia — COMPLETED · PHASE2
• Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim — COMPLETED · PHASE3
• Study to Assess the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GW003 in Patients With Breast Cancer — OTHER · PHASE1
• Tolerability and Pharmacokinetics(PK)/Pharmacodynamics(PD) Study of GW003 in Healthy Subjects — COMPLETED · PHASE1
• Fusion Protein rHSA/GCSFclinical Study on Breast Cancer Patients — COMPLETED · PHASE1
• Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Neulasta® — COMPLETED · PHASE3
• Study of Recombinant Human Serum Albumin/Granulocyte Colony-Stimulating Factor Fusion Protein — COMPLETED · PHASE2
• Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast Cancer — COMPLETED · PHASE2
• Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients — COMPLETED · PHASE3
• Evaluation of the Food Effect on the Safety, Tolerability, PK of EC-18 After Oral Administration in Healthy Volunteers — COMPLETED · PHASE1
• Safety and Pharmacokinetic(PK) Study of GW003 to Metastatic Tumors — COMPLETED · PHASE1
• Study to Evaluate the Safety, Tolerability and PK of EC-18 After Oral Administration in Healthy Volunteers — COMPLETED · PHASE1
• A Safety and PK Study of EC-18 in Healthy Subjects — COMPLETED · PHASE1
• HEXAFIL: Non-interventional study for supportive treatment of chemotherapy induced neutopenia with Filgrastim HEXAL® — OTHER
• Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia — COMPLETED · PHASE3
• Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia — COMPLETED · PHASE2

Refine this search